Skip to main content
Signal8
Eylward Susan profile photo

Susan Eylward

CIK: 0002039135

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (37.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)10 (62.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Imunon, Inc. logo
IMNN

Imunon, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Aug 31, 2026
    Sale(S)
    Direct
    2.5K shares at avg. $1.56$4K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Aug 28, 2026
    Award(A)
    Direct
    2.5K shares at avg. $1.60$4K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Aug 17, 2026
    Sale(S)
    Direct
    2.4K shares at avg. $1.63$4K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Aug 14, 2026
    Award(A)
    Direct
    2.4K shares at avg. $1.65$4K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Aug 3, 2026
    Sale(S)
    Direct
    2.5K shares at avg. $1.57$4K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jul 31, 2026
    Award(A)
    Direct
    2.5K shares at avg. $1.59$4K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jul 20, 2026
    Sale(S)
    Direct
    2.2K shares at avg. $1.78$4K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jul 17, 2026
    Award(A)
    Direct
    2.2K shares at avg. $1.83$4K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jul 6, 2026
    Sale(S)
    Direct
    920 shares at avg. $1.88$2K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jul 2, 2026
    Award(A)
    Direct
    920 shares at avg. $1.91$2K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jun 29, 2026
    Sale(S)
    Direct
    11.8K shares at avg. $1.75$21K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jun 25, 2026
    Award(A)
    Direct
    14.7K shares at avg. $1.72$25K
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Jan 2, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    8.3K shares-
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Aug 4, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    417 shares-
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Mar 14, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    6.3K shares-
  • Imunon, Inc. logo
    IMNN

    Imunon, Inc.

    Oct 7, 2024
    Award(A)

    Stock Option (Right to Buy)

    Direct
    50K shares-

1-16 of 16

About Eylward Susan

Eylward Susan (SEC CIK 0002039135) files insider reports with the SEC as General Counsel and Corp Sec of Imunon, Inc. (IMNN).

Signal8 holds 11 ownership filings by Eylward Susan (1 Form 3, 10 Form 4), filed between Oct 7, 2024 and Sep 1, 2026. Those filings report 16 transactions, from Oct 7, 2024 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Eylward Susan's filings is in LAWRENCEVILLE, NJ.

Recent filings by Eylward Susan

  • Aug 31, 2026: Open-market sale of IMNN shares (Form 4, code S).
  • Aug 28, 2026: Grant or award of IMNN shares (Form 4, code A).
  • Aug 17, 2026: Open-market sale of IMNN shares (Form 4, code S).
  • Aug 14, 2026: Grant or award of IMNN shares (Form 4, code A).
  • Aug 3, 2026: Open-market sale of IMNN shares (Form 4, code S).

Other insiders filing for Imunon, Inc. (IMNN)

How to read Form 4 transaction codes